FBMCX | HBLYX | FBMCX / HBLYX | |
Total Expense Ratio | 1.65 | 0.67 | 246% |
Annual Report Gross Expense Ratio | 1.66 | 0.67 | 248% |
Fund Existence | 19 years | 19 years | - |
Gain YTD | 4.459 | 6.703 | 67% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 250000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 3.33B | 11.9B | 28% |
Annual Yield % from dividends | 3.61 | 3.51 | 103% |
Returns for 1 year | 4.04 | 5.38 | 75% |
Returns for 3 years | 15.71 | 15.46 | 102% |
Returns for 5 years | 22.92 | 16.51 | 139% |
Returns for 10 years | 37.97 | 45.27 | 84% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FTZFX | 55.36 | 0.67 | +1.23% |
FullerThaler Behvrll Uncnstd Eq R6 | |||
NBGAX | 62.25 | 0.34 | +0.55% |
Neuberger Berman Genesis Adv | |||
OILGX | 26.07 | 0.11 | +0.42% |
Optimum Large Cap Growth Instl | |||
NEIMX | 33.97 | 0.10 | +0.30% |
Neiman Large Cap Value No-Load | |||
FTDZX | 132.76 | -0.26 | -0.20% |
Franklin Biotechnology Discovery Adv |